Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for NexGel Inc. (NXGLW:NASDAQ), powered by AI.
NexGel Inc. is currently trading at $0.06. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for NexGel Inc. on Alpha Lenz.
View NexGel Inc.'s valuation metrics on Alpha Lenz.
“NexGel Inc.'s ROE is -62.8%. Explore profitability and growth together.”
Ask for details →NexGel Inc. operates as a biotechnology company, specializing in the development and production of advanced, high-performance hydrogels. These hydrogels are designed for use in a variety of medical and consumer applications, ranging from wound care and medical diagnostics to skin care products. The company's primary function is to leverage its proprietary hydrogel technologies to create products that provide superior hydration, flexibility, and comfort. Notable sectors impacted by NexGel's solutions include healthcare, cosmetic industries, and consumer goods. In the financial market, NexGel Inc. represents a unique niche sitting at the intersection of biotechnology and consumer health, reflecting growing trends in personalized and high-tech care solutions. The company plays a crucial role in advancing healthcare applications by offering customizable and innovative materials that can enhance product performance and patient experience.
“NexGel Inc.'s ROE is -62.8%. Explore profitability and growth together.”
Ask for details →NexGel Inc. (ticker: NXGLW) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 19 employees.
The current price is $0.055 with a P/E ratio of -x and P/B of -x.
ROE is -62.78% and operating margin is -40.91%. Annual revenue is $9M.